HIV-1 reservoir evolution in infants infected with clade C from Mozambique
- PMID: 36476348
- PMCID: PMC9892347
- DOI: 10.1016/j.ijid.2022.11.042
HIV-1 reservoir evolution in infants infected with clade C from Mozambique
Abstract
Background: The persistence of HIV-1-infected cells during antiretroviral therapy is well documented but may be modulated by early initiation of antiretroviral therapy in infants.
Methods: Here, we longitudinally analyzed the proviral landscape in nine infants with vertical HIV-1 infection from Mozambique over a median period of 24 months, using single-genome, near full-length, next-generation proviral sequencing.
Results: We observed a rapid decline in the frequency of intact proviruses, leading to a disproportional under-representation of intact HIV-1 sequences within the total number of HIV-1 DNA sequences after 12-24 months of therapy. In addition, proviral integration site profiling in one infant demonstrated clonal expansion of infected cells harboring intact proviruses and indicated that viral rebound was associated with an integration site profile dominated by intact proviruses integrated into genic and accessible chromatin locations.
Conclusion: Together, these results permit rare insight into the evolution of the HIV-1 reservoir in infants infected with HIV-1 and suggest that the rapid decline of intact proviruses, relative to defective proviruses, may be attributed to a higher vulnerability of genome-intact proviruses to antiviral immunity. Technologies to analyze combinations of intact proviral sequences and corresponding integration sites permit a high-resolution analysis of HIV-1 reservoir cells after early antiretroviral treatment initiation in infants.
Keywords: Evolution; HIV-1; Infants; Integration sites; Reservoir.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have no competing interests to declare.
Figures


References
-
- UNAIDS Global HIV statistics. Geneva: UNAIDs; 2020.
-
- UNAIDS UNAIDS data 2021. Geneva: UNAIDs; 2021.
-
- Luzuriaga K, Tabak B, Garber M, YaH Chen, Ziemniak C, McManus MM, Murray D, et al. HIV Type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment. J Infect Dis 2014;210:1529–38. doi: 10.1093/infdis/jiu297. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
- K24 AI155233/AI/NIAID NIH HHS/United States
- U01 AI135940/AI/NIAID NIH HHS/United States
- R01 AI127347/AI/NIAID NIH HHS/United States
- D43 TW010543/TW/FIC NIH HHS/United States
- R01 AI152979/AI/NIAID NIH HHS/United States
- R01 AI130005/AI/NIAID NIH HHS/United States
- UM1 AI164560/AI/NIAID NIH HHS/United States
- P30 AI073961/AI/NIAID NIH HHS/United States
- R01 AI120008/AI/NIAID NIH HHS/United States
- UM1 AI164566/AI/NIAID NIH HHS/United States
- P30 AI060354/AI/NIAID NIH HHS/United States
- UM1 AI164562/AI/NIAID NIH HHS/United States
- U01 HL146203/HL/NHLBI NIH HHS/United States
- UM1 AI164570/AI/NIAID NIH HHS/United States
- U01 AI114235/AI/NIAID NIH HHS/United States
- U01 AI117841/AI/NIAID NIH HHS/United States
- R01 DK120387/DK/NIDDK NIH HHS/United States
- D43 TW009610/TW/FIC NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases